In vertebrates, the periodic formation of somites from the presomitic mesoderm (PSM) is driven by the molecular oscillator known as the segmentation clock. The hairy-related gene, hes6/her13.2, functions as a hub by dimerizing with other oscillators of the segmentation clock in zebrafish embryos. Although hes6 exhibits a posterior-anterior expression gradient in the posterior PSM with a peak at the tailbud, the detailed mechanisms underlying this unique expression pattern have not yet been clarified. By establishing several transgenic lines, we found that the transcriptional regulatory region downstream of hes6 in combination with the hes6 3′UTR recapitulates the endogenous gradient of hes6 mRNA expression. This downstream region, which we termed the PT enhancer, possessed several putative binding sites for the T-box and Ets transcription factors that were required for the regulatory activity. Indeed, the T-box transcription factor (Tbx16) and Ets transcription factor (Pea3) bound specifically to the putative binding sites and regulated the enhancer activity in zebrafish embryos. In addition, the 3′UTR of hes6 is required for recapitulation of the endogenous mRNA expression. Furthermore, the PT enhancer with the 3′UTR of hes6 responded to the inhibition of retinoic acid synthesis and fibroblast growth factor signaling in a manner similar to endogenous hes6. The results showed that transcriptional regulation by the T-box and Ets transcription factors, combined with the mRNA stability given by the 3′UTR, is responsible for the unique expression gradient of hes6 mRNA in the posterior PSM of zebrafish embryos.
Introduction
Somites, transient epithelial structures of the paraxial mesoderm, are periodically segmented from the anteriormost portion of the unsegmented paraxial mesoderm known as the presomitic mesoderm (PSM). The periodicity of somite formation is governed by an internal molecular oscillator, the segmentation clock, which exhibits cyclic gene expression in the PSM (Hubaud and Pourquié, 2014; Oates et al., 2012; Saga and Takeda, 2001) . This oscillatory expression is characterized by a tightly coordinated periodicity that approximates a wave of expression that travels through the PSM in a posterior-anterior direction during somitogenesis. Most of the genes that exhibit cyclic expression in the PSM are associated with the Notch signaling pathway. For example, the hairy/Enhancer of split-related genes that encode bHLH transcription factors, such as c-hairy1 in chickens (Palmeirim et al., 1997) , Hes7 in mice (Bessho et al., 2001) , and her1 and her7 (her1/7) in zebrafish (Henry et al., 2002; Holley et al., 2000) , are all central components of the oscillation machinery and have been shown to exhibit oscillatory gene expression patterns in the PSM. The negative feedback loop involving these genes comprises the core oscillator of the segmentation clock (Bessho et al., 2003; Giudicelli and Lewis, 2004) . Loss of function or overexpression of these cyclic genes results in disruption of the somite boundaries in mouse (Bessho et al., 2001 ) and zebrafish (Henry et al., 2002; Holley et al., 2002; Oates and Ho, 2002) . In the posterior PSM, the cyclic expression of hairy-related genes is synchronized among neighboring cells via cell-to-cell interactions that are mediated by theclock are tightly coordinated by mutually antagonistic gradients between retinoic acid (RA) and fibroblast growth factor (FGF) signaling (Hubaud and Pourquié, 2014; Oates et al., 2012) . Whereas the anterior-posterior gradient of RA, which is synthesized by RALDH2 in the anterior PSM and newly formed somites, activates the genes involved in segmentation, the opposing gradient of FGF signaling maintains the immature state and cyclical gene expression in the posterior PSM.
In zebrafish, another hairy-related gene, hes6 (previously named her13.2), acts as a hub for oscillators in the segmentation clock (Schröter et al., 2012) . Hes6 proteins form a transcriptional repressor complex with other cyclic Her proteins that participate in the periodic repression of the Notch-regulated genes her1 and her7 (Kawamura et al., 2005; Trofka et al., 2012) . Distinct from other cyclic hairy-related genes, such as her1/7 expressed in the PSM (Henry et al., 2002; Holley et al., 2000) , the expression of hes6 mRNA is static and forms a posterior-anterior gradient, which is regulated by FGF signaling and not by Notch signaling (Kawamura et al., 2005 ). Thus, hes6 shows an atypical expression profile among the segmentation genes and is considered to be required for the proper expression of other oscillatory genes in the posterior PSM (Kawamura et al., 2005) . However, the molecular mechanisms underlying the gradient of hes6 expression in the posterior PSM remain unknown.
In the current study, we have identified the transcriptional regulatory region, PT enhancer, downstream of the hes6 locus that drives the expression of reporter genes in the PSM and tailbud. By establishing stable transgenic lines, we demonstrated that the PT enhancer cannot elicit the posterior-anterior gradient of hes6 mRNA expression on its own, and that a combined function of the PT enhancer and the 3′UTR of hes6 was enough for recapitulating the expression gradient. Our results suggest that both the transcriptional regulation and 3′UTR-dependent mRNA turnover is responsible for the gradient of hes6 mRNA expression in the posterior PSM and tailbud.
Materials and methods

Fish maintenance
Zebrafish (Danio rerio) were maintained at 27°C with a 14-h light/10-h dark cycle. Embryos were incubated at 28.5°C until they reached the appropriate stages. The morphological features and hours post-fertilization (hpf) were used to stage embryos (Kimmel et al., 1995) . All experiments using live fish complied with the protocols approved by the Committee for Animal Care and Use of Saitama University.
Construction of plasmids
DNA fragment for the promoter of zebrafish hsp70l, the coding region of enhanced green fluorescent protein gene (EGFP), and the SV40 late polyadenylation signal (SV40pA) were inserted into the vector pTol2-MCS (Nakayama et al., 2013) . The constructed vector pTol2-hspEGFP was used as the backbone vector in this study. For pTol2-PT enhancer-hspEGFP, a 1.7-kb DNA sequence downstream of the hes6 locus was amplified by PCR from the zebrafish bacterial artificial chromosome (BAC), CHORI73-20O6, and inserted upstream of the hsp70l promoter in pTol2-hspEGFP. Base substitutions in the T-box and Ets binding sites of pTol2-PT enhancerhspEGFP were introduced using inverse PCR and confirmed by DNA sequencing.
To construct pCS2þ tbx16 and pCS2þpea3, DNA fragments that corresponded to the entire open reading frames of tbx16 and pea3, respectively, were amplified by PCR and inserted into the multicloning sites of the pCS2þ vector. To construct pCS2þtbx16-EnR and pCS2 þpea3-EnR, DNA fragments that encoded the T-domain of Tbx16 protein (amino acids 1-260) and the DNA fragments that encoded the Ets domain of Pea3 protein (amino acids 345-432), respectively, were inserted in-frame upstream of the Drosophila Engrailed repressor domain in the pCS2 þENG-RD vector (kindly donated by Dr. Mami Matsuo-Takasaki).
Microinjection into zebrafish embryos
To synthesize capped mRNA, template plasmids were linearized with appropriate restriction enzymes and transcribed with SP6 RNA polymerase using the MEGAscript SP6 Kit (Ambion) according to the manufacturer's protocol. Next, 1-2 nl of the capped mRNA was injected into 1-4-cell-stage embryos.
For reporter gene analyses, 1-2 nl of the reporter gene plasmids or BAC EGFP reporters was injected into the 1-4-cell-stage embryos at a concentration of 10 ng/μl.
BAC homologous recombination in bacteria SW102
Four zebrafish BAC clones used in this study were purchased from BACPAC Resources Center (http://bacpac.chori.org/). To generate the BAC EGFP reporter, a DNA fragment that contained EGFP, 3′UTR and the polyadenylation signal from bovine growth hormone, and a kanamycin resistance gene was amplified by PCR as described previously (Kimura et al., 2006) . The sequences of primers used are 5′-GAACCCGCCGACCATCTGCCCCCCATTCAAGCGTCCT-GAACTGCAGCAATATGGTGAGCAAGGGCGAGG-3′ and 5′-TTCTGTG GGTGATTAAAAGACGTGTTTGCGTACCTTTCTGTCTTTTATTCCAGTTGG TGATTTTGAACTT-3′. The PCR product was inserted into the translation start codon of the first exon of the hes6 gene in BAC clones via homologous recombination in SW102 bacteria, as described previously (Lee et al., 2001) . For the deletion analysis of the CHOR211-20O6 BAC EGFP reporter, the candidate DNA fragment in BAC was replaced with a beta-lactamase gene or streptomycin resistance gene via homologous recombination. The correct replacements of the 5′ or 3′ regions in the desired sites were confirmed by PCR and DNA sequencing.
Generation of transgenic fish line
To generate transgenic fish lines, we used the Tol2 transposon system (Kawakami, 2005) . In brief, the pTol2-based EGFP reporter plasmid (10 ng/μl) was co-injected into fertilized embryos with Tol2 transposase mRNA (25 ng/μl) and the injected embryos were raised to adulthood. Transgenic fish lines were isolated on the basis of fluorescence expression in the F1 embryos obtained from the injected fish. After mating matured F1 fish with wild-type fish, single integration of the transgenes in the genome was confirmed by showing that the inheritance followed the Mendelian law.
Electrophoretic mobility shift assay (EMSA)
EMSA was performed as described previously (Inoue et al., 2008) . DNA fragments were labeled with digoxigenin as a probe. In vitro synthesized proteins were prepared using pCS2 þtbx16 or pCS2þpea3 as templates with the TnT Quick Coupled Transcription/Translation System (Promega).
Whole-mount in situ hybridization
Digoxigenin-labeled RNA probes were synthesized with DIG RNA Labeling Mix (Roche Diagnostic) according to the manufacturer's protocol. Whole-mount in situ hybridization was performed as described previously (Nikaido et al., 1997) .
Two-color fluorescence in situ hybridization
Two-color fluorescence in situ hybridization was performed essentially as described previously (Brend and Holley, 2009b) . Images were taken by a laser-scanning confocal microscopy (Olympus FV1000).
2.9. Chemical treatments on zebrafish embryos SU5402 (Wako) treatment was carried out as described previously (Kawamura et al., 2005; Sawada et al., 2001) . Manually dechorionated embryos at 1-2-somite stage were incubated for 8 min at a concentration of 0.2 mg/ml SU5402. After the fourtimes wash, the treated embryos were subsequently fixed and subjected to whole-mount in situ hybridization.
4-Diethylamino benzaldehyde (DEAB; Sigma-Aldrich) was used to inhibit RA synthesis. The embryos were incubated in the medium containing DEAB at a concentration of 10 μM from the sphere stage and fixed at the 8-10-somite stage.
Results
Identification of the PT enhancer of hes6 in zebrafish
To understand the molecular mechanisms underlying the establishment of a gradient of hes6 expression in the posterior PSM and tailbud, we attempted to identify the transcriptional regulatory region(s) that drive hes6 expression. We constructed BACbased EGFP reporters to survey several hundred kilobases of the genomic region that contains hes6. As shown in Fig. 1A , four BAC clones that encompassed the hes6 locus were modified by inserting the EGFP reporter gene into the first exon of hes6 via homologous recombination in bacteria (Lee et al., 2001) . Although transient expression of the introduced genes in zebrafish embryos tended to be mosaic, with more or less ectopic patterns, injection of the CHORI73-20O6 BAC EGFP reporter yielded specific EGFP signals in the somites, PSM, and tailbud at the 6-somite stage (Fig. 1B) , which included the endogenous expression of hes6 (Kawamura et al., 2005) . In addition, three other similarly modified BAC EGFP reporters induced comparable expression. Thus, posteriorly restricted expression of the EGFP reporters observed here suggest that the transcriptional regulatory element(s) required for hes6 expression in the PSM and tailbud are located within the BAC sequences employed.
To functionally dissect the genomic region flanking hes6, different DNA fragments in the CHORI73-20O6 BAC EGFP reporter were replaced with the fragment with an ampicillin-resistance beta-lactamase gene, or a streptomycin resistance gene, via homologous recombination in bacteria. Subsequent reporter analyses showed that a 5.5-kb DNA fragment in the intergenic region between hes6 and the circadian clock gene, per2, was required for the transcriptional regulatory activities that drive EGFP expression in the PSM and tailbud (Fig. 1C ). This 5.5-kb region was divided into several DNA fragments, each of which was then inserted upstream of the promoter for the hsp70l gene, which exhibits a basal activity in the absence of heat-shock (Blechinger et al., 2002) , and was connected to the EGFP reporter gene (Fig. 1D) . Injection of each reporter construct demonstrated that a 1.7-kb DNA fragment between þ2.8 kb and þ4.5 kb from the translation start site of hes6 exhibited enhancer activity and induced expression in the somites, PSM, and tailbud (Fig. 1E ). Since this specific expression of EGFP overlapped with endogenous hes6 expression in the posterior PSM and tailbud, this 1.7-kb DNA fragment between þ2.8 kb and þ 4.5 kb was designated as the PSM and tailbud (PT) enhancer.
To evaluate the precise regulatory activity of the PT enhancer, we established stable transgenic lines, Tg(hes6:EGFP-SV40pA), which possessed the PT enhancer fused to the hsp70l-driven EGFP gene and SV40pA, using the Tol2 transposon system ( Fig. 2A ). In Tg (hes6:EGFP-SV40pA) embryos, the EGFP signal was initially detected in the tailbud around the bud stage ( Fig. 2B -E). Relatively strong fluorescence was observed at the posterior end of the notochord in the tailbud (arrowhead in Fig. 2D ). Subsequently, at the 18-somite stage, EGFP fluorescence was observed in the somites, PSM, and tailbud ( Fig. 2F and G). At 24 hpf, the EGFP signal in the somites appeared to have decreased toward the anterior somites, whereas the fluorescence persisted in the posterior somites ( Fig. 2H and I ). Next, we compared the expression patterns of EGFP mRNA in Tg(hes6:EGFP-SV40pA) embryos with the endogenous expression of hes6 during embryogenesis by whole-mount in situ hybridization ( Fig. 2J-W) . At 50% epiboly, although EGFP fluorescence was not yet detected, a weak EGFP mRNA signal consistent with initial endogenous hes6 expression was observed in the blastoderm margin ( Fig. 2J -M) (Kawamura et al., 2005) . At the bud stage, the expression patterns of EGFP and hes6 in the PSM and tailbud were comparable ( Fig. 2N-Q) . At the 12-somite stage, EGFP mRNA was again detected in the PSM and tailbud in Tg(hes6:EGFPSV40pA) embryos ( Fig. 2R -U). Although hes6 showed a posterioranterior expression gradient within the PSM, the expression of EGFP did not exhibit any similar gradient; instead, EGFP expression was expressed ubiquitously in the PSM and was observed ectopically throughout the somites. At 24 hpf, the EGFP signal persisted in the tail region in a manner similar to endogenous hes6 expression ( Fig. 2V-W) . A relatively weak signal of EGFP mRNA was still observed in the posterior somites, and ectopic expression was also observed in the midbrain and otic placodes. Thus, the expression patterns of EGFP in the transgenic fish were generally similar to hes6 mRNA distribution; however, compared with hes6 mRNA, EGFP expression was more broadly discernible, particularly in somites. Thus, we conclude that the PT enhancer possesses an enhancer activity that is involved in the endogenous expression of hes6 in the PSM and tailbud, but that the PT enhancer cannot on its own recapitulate the hes6 expression gradient in the PSM.
T-box and Ets transcription factor binding sites in the PT enhancer are required for enhancer activity in the PSM and tailbud
To explore the regulatory mechanism of the PT enhancer, putative transcription factor binding sites were identified using the Patch 1.0 program (http://www.gene-regulation.com/pub/programs.html). The putative binding sites for T-box and Ets transcription factors identified with the program were clustered in a 156-bp DNA region at þ3.6 kb (Fig. 3A) . The two T-box binding sequences in this 156-bp region, located close to each other on opposite DNA strands, were identical to the consensus binding sequence of T-box transcription factors (5′-TCACACCT-3′) and were flanked by three Ets binding sites (Goering et al., 2003; Scott et al., 1994) . In zebrafish, several T-box genes such as ntla, tbx6, and tbx16 are expressed in the PSM and/or tailbud, and their gene products were shown to bind to this 5′-TCACACCT-3′ in vitro or in embryos (Garnett et al., 2009; Morley et al., 2009; Windner et al., 2015) . On the other hand, several Ets genes, such as pea3, etv5a, and etv5b/erm, are also expressed in the regions where hes6 is expressed (Raible and Brand, 2001; Chen et al., 2013) . Of note, Ets transcription factors function as downstream mediators of FGF signaling (Raible and Brand, 2001) , and the expression of hes6 is regulated by FGF signaling (Kawamura et al., 2005) .
We then examined the effects of substitutions at these binding sites in the PT enhancer (Fig. 3B-L) . Injection of the intact PT enhancer-hsp70l-EGFP reporter produced signals in the PSM and tailbud ( Fig. 3E and F) . By contrast, disruption of the core regions of the two T-box binding sites in the PT enhancer (5′-TCAATCCT-3′, introduced mutations are underlined) greatly reduced the enhancer activity in the PSM and tailbud ( Fig. 3G and H) . Mutations in either of the two T-box sites did not reduce the EGFP signal (data not shown), suggesting that each of the T-box sites is sufficient for the enhancer activity. Likewise, base substitutions in the core regions of all three putative Ets binding sites reduced the enhancer activity in the PSM and tailbud ( Fig. 3I and J) . Compared to the mutations in the two T-box binding sites, mutations in the Ets binding sites were less effective in decreasing the enhancer activity. Finally, the simultaneous disruption of the two Tbx and three Ets sites greatly diminished the PT enhancer activity ( Fig. 3K and L). These results indicate that the cluster of T-box and Ets binding sites in the PT enhancer acts as a core regulatory element and is responsible for the regulatory activity in the PSM and tailbud.
Merge EGFP
3.3. T-box transcription factor,Tbx16, and Ets transcription factor, Pea3, bind to the PT enhancer in vitro
We showed that the T-box and Ets binding sites are required for the PT enhancer activity in the PSM and tailbud. We therefore performed the EMSA to examine whether the T-box and Ets transcription factors can bind to the PT enhancer. The probes used were the 24-bp DNA fragment (T1) containing one of the T-box binding sites and the 21-bp DNA fragment (E1) containing one of the Ets sites (Fig. 4A) . Base substitutions were introduced into the core sequences of T1 and E1 (Goering et al., 2003; Scott et al., 1994) . As mentioned above, Ntla, Tbx6, and Tbx16 were shown to bind to the 5′-TCACACCT-3′ (Garnett et al., 2009; Morley et al., 2009; Windner et al., 2015) . Among these T-box transcription factors, we examined whether Tbx16 is able to bind to the PT enhancer. Our findings showed that the in vitro-synthesized Tbx16 protein indeed bound to T1 (Fig. 4B) . In addition, the specificity of binding was verified by abrogation of the shifted bands by excess amount of non-labeled T1 oligo but not by the mutT1 competitor. Next, we investigated whether Pea3, among the several Ets genes expressed in the PSM and tailbud (Chen et al., 2013; Raible and Brand, 2001) , could bind to the PT enhancer. EMSA showed that the in vitro-synthesized Pea3 bound directly to the E1 fragment (Fig. 4C) . The specificity of this binding was confirmed by excess non-labeled E1 oligo, but not by mutE1 oligo. These results suggest that T-box and Ets transcription factors bind to the PT enhancer in a specific manner.
PT enhancer is regulated by T-box and Ets transcription factors in zebrafish embryos
We then examined whether the PT enhancer is regulated by T-box and Ets transcription factors in zebrafish embryos. In general, T-box factors function as transcriptional activators (Conlon et al., 1996) . We therefore injected Tg(hes6:EGFP-SV40pA) embryos with tbx16 mRNA and examined the EGFP expression. The expression of EGFP was detected at 60% epiboly in the blastoderm margin of the control embryos, whereas EGFP expression was induced in the tbx16 mRNA-injected embryos ( Fig. 5A and B) . We then injected Tg(hes6:EGFP-SV40pA) embryos with tbx16-EnR mRNA that encoded the T-domain of Tbx16 fused to the Engrailed repressor domain. The expression of EGFP was detected at 60% epiboly in the blastoderm margin of the control embryos, whereas EGFP expression was greatly reduced in the tbx16-EnR mRNAinjected embryos (Fig. 5C and D) . These results suggest that the PT enhancer is regulated by T-box transcription factors in embryos.
To examine whether the PT enhancer is also regulated by Ets transcription factors in embryos, we injected pea3 mRNA into Tg (hes6:EGFP-SV40pA) embryos and examined EGFP expression at 60% epiboly. Compared with control embryos, the expression of EGFP was increased in the blastoderm margin in pea3 mRNA-injected embryos (Fig. 5E, F) , suggesting that Pea3 activates the transcription of EGFP. Thus, we fused the Ets-domain of Pea3 to the Engrailed repressor domain (i.e., the pea3-EnR). Injection of pea3-EnR mRNA into Tg(hes6:EGFP-SV40pA) embryos extensively downregulated EGFP expression at 60% epiboly ( Fig. 5G and H) . However, injection of antisense morpholino oligos (MO) specific to tbx16 and pea3 respectively did not affect the expression of EGFP reporter gene (Supplementary Fig. 1 ), suggesting the redundancy with other T-box and Ets transcription factors. Overall, these results suggest that the PT enhancer in zebrafish embryos is regulated by the T-box and Ets transcription factors.
3.5. Combination of the PT enhancer and hes6 3′UTR is sufficient to recapitulate the posterior-anterior gradient of hes6 mRNA expression within PSM Although EGFP mRNA was expressed in the PSM and tailbud in Tg(hes6:EGFP-SV40pA) embryos, the posterior-anterior gradient in the PSM was not recapitulated and ectopic expression of EGFP was observed in the somites (Fig. 2R-U) . We assumed an additional regulatory mechanism that endowed hes6 with a gradient expression pattern within the PSM. One such candidate is 3′UTR, as a previous report showed that the 3′UTR of zebrafish her1 can restrict reporter gene expression in the PSM (Brend and Holley, 2009a) . To examine this possibility, we replaced the SV40pA in the PT enhancer-EGFP reporter with the 3′UTR of hes6 ( Fig. 2A) and generated stable transgenic lines, Tg(hes6:EGFP-hes6 3′UTR), using the Tol2 transposon system (Fig. 6A) . In Tg(hes6:EGFP-hes6 3′UTR) embryos, EGFP fluorescence was observed in the somites, PSM, and tailbud in a manner similar to Tg(hes6:EGFP-SV40pA) embryos at the 18-somite stage ( Supplementary Fig. 2 ). Next, we compared the EGFP mRNA expression in Tg(hes6:EGFP-hes6 3′UTR) embryos with those in Tg(hes6:EGFP-SV40pA) embryos (Fig. 6B-O) . In both transgenic lines, the expression of EGFP mRNA was observed in the blastoderm margin at 50% epiboly ( Fig. 6B-E ) and in the tailbud at the bud stage (Fig. 6F-I ). During somitogenesis, EGFP-SV40pA mRNA was detected in the PSM, tailbud, and somites (Fig. 6J, L and  N) , whereas the distribution of EGFP-hes6 3′UTR mRNA in Tg(hes6: EGFP-hes6 3′UTR) embryos was restricted to the PSM and tailbud, and exhibited a posterior-anterior gradient within the PSM (Fig. 6K, M and O). It should be noted that similar expression of EGFP mRNA was observed in embryos from two different founders for either of Tg(hes6:EGFP-SV40pA) and Tg(hes6:EGFP-hes6 3′UTR). These observations suggest that the differential reporter expression patterns between Tg(hes6:EGFP-SV40pA) and Tg(hes6:EGFPhes6 3′UTR) were not caused by the differences of integration sites of reporter genes, but by the differences of the 3′UTR. To precisely compare the expression patterns of EGFP-hes6 3′ UTR and endogenous hes6 mRNAs, we next performed two-color fluorescence in situ hybridization at the 10-12-somite stage.
Although the expression of EGFP-SV40pA mRNA was not restricted to the PSM, but extended to the somites, the distribution of EGFPhes6 3′UTR mRNA clearly exhibited a posterior-anterior gradient that coincided with that of endogenous hes6 mRNA expression restricted to the PSM (Fig. 7B-G) . Importantly, the anterior limit of the expression domain was comparable between EGFP-hes6 3′UTR and hes6 mRNAs in Tg(hes6:EGFP-hes6 3′UTR) embryos. These findings showed that the combination of the PT enhancer and 3′ UTR of hes6 is capable of recapitulating the endogenous gradient expression of hes6 in the PSM.
We also generated another transgenic line, Tg(hes6:EGFP-hes6 3′UTR-SV40pA), that possessed the PT enhancer fused to the hsp70l-driven EGFP gene and both of the 3′UTRs of hes6 and SV40pA (Fig. 7A) and examined the expression of the reporter gene. Although EGFP-hes6 3′UTR-SV40pA mRNA was a little more anteriorly expressed than the mRNA of the endogenous hes6, the expression pattern of EGFP-hes6 3′UTR-SV40pA mRNA was similar to that of EGFP-hes6 3′UTR mRNA, but not to that of EGFP-SV40pA mRNA (Fig. 7B-J) . In addition, we performed heat-shocks and examined the decay of the induced EGFP mRNAs in Tg(hes6:EGFPSV40pA), Tg(hes6:EGFP-hes6 3′UTR), and Tg(hes6:EGFP-hes6 3′UTR-SV40pA) embryos (Supplementary Fig. 3 ). Whole-mount in situ hybridization and quantitative PCR revealed that EGFP-hes6 3′UTR and EGFP-hes6 3′UTR-SV40pA mRNAs showed a similar rate of mRNA turnover. These results indicate that the hes6 3′UTR endows the mRNA with turnover rates required for accurate replication of the endogenous spatial expression profile.
3.6. Expression of EGFP in Tg(hes6:EGFP-hes6 3′UTR) responds to treatments affecting FGF and RA signaling in a manner similar to endogenous hes6 expression.
Along the PSM, antagonistic gradients of FGF signaling and RA control the expression of genes involved in a segmentation clock (Hubaud and Pourquié, 2014; Oates et al., 2012) . Indeed, hes6 expression was shown to be controlled by FGF signaling (Kawamura et al., 2005; Stulberg et al., 2012) . To investigate whether EGFPhes6 3′UTR mRNA is also regulated by FGF signaling, we compared the effects of transient treatment with SU5402, a chemical inhibitor of FGF signaling, on EGFP expression in Tg(hes6:EGFP-hes6 3′UTR) at the 1-2-somite stage. As was observed previously (Kawamura et al., 2005) , transient exposure to SU5402 at the 1-2-somite stage reduced the expression of hes6 mRNA in the PSM of embryos (Fig. 7M and N) . Consistent with the endogenous hes6 expression, the expression of EGFP-hes6 3′UTR mRNA was significantly reduced in the PSM by SU5402 treatment compared to the control embryos (Fig. 7K and L) .
To examine whether RA also regulates the gradient of hes6 expression, we treated the embryos using DEAB, a chemical inhibitor of RA synthesis. Treatment with DEAB from the sphere stage resulted in anterior expansion of hes6 mRNA compared with the control embryos at the 10-12-somite stage ( Fig. 7Q and R) . These results suggest that the gradient of hes6 expression in the PSM is regulated by RA. Then, we investigated whether EGFP-hes6 3′UTR mRNA is also regulated by RA. Of note, DEAB treatment resulted in the anterior expansion of EGFP-hes6 3′UTR expression in a manner similar to that of hes6 ( Fig. 7O and P) . These results imply that the EGFP-hes6 3′UTR recapitulates the altered expression of hes6 through the inhibition of FGF signaling and RA synthesis. Moreover, our results suggest that the mutually opposed gradients of RA and FGF signaling are translated into the gradient of hes6 expression.
Discussion
In this study, we revealed the transcriptional regulatory sequence downstream of hes6, the PT enhancer, which drives gene expression in the PSM and tailbud of zebrafish embryos. We also demonstrated that both T-box and Ets transcription factors bind to the PT enhancer in a specific manner and regulate the enhancer activity. In addition, the posterior-anterior gradient of hes6 mRNA expression in the PSM is recapitulated by the presence of both the PT enhancer and the hes6 3′UTR. Moreover, we also showed that the expression of EGFP-hes6 3′UTR mRNA responds to the inhibition of FGF signaling and RA synthesis, respectively, similarly to the endogenous expression of hes6. Thus, our results showed that the transcriptional regulation and the mRNA stability given by the 3′UTR are sufficient to replicate the posterior-anterior gradient of hes6 expression within the zebrafish PSM.
PT enhancer with hes6 3′UTR recapitulates the endogenous gradient of hes6 mRNA expression in the PSM
The posterior-anterior gradient of hes6 expression in the PSM is static and is distinct from the expression of other her genes, which show cyclical expression. We identified the PT enhancer that drives transcription in the PSM and tailbud. Indeed, in Tg (hes6:EGFP-SV40pA) embryos, the expression of EGFP-SV40pA was observed in the PSM and tailbud. However, it ectopically extended into the somitic regions, showing that the PT enhancer is not enough for recapitulation of the gradient of hes6 expression. In contrast, EGFP expression in Tg(hes6:EGFP-hes6 3′UTR) embryos clearly showed a posterior-anterior gradient in the PSM, as does the endogenous expression of hes6. As similar expression patterns of EGFP were observed in embryos from different founders for both Tg(hes6:EGFP-SV40pA) and Tg(hes6:EGFP-hes6 3′UTR) lines, we consider that the ectopic expression of EGFP in the somites of Tg (hes6:EGFP-SV40pA) is probably attributed to the differences in the stability of EGFP-SV40pA and EGFP-hes6 3′UTR mRNAs and not to sustained transcription in the somites. In addition, the expression pattern of EGFP-hes6 3′UTR mRNA was altered similarly to endogenous hes6 by the inhibition of FGF signaling and RA synthesis. Although we cannot exclude the possibility that other regulatory element(s) may be involved in the regulation of hes6 expression in zebrafish PSM, our results indicate that the combinatorial functions of the PT enhancer and hes6 3′UTR are sufficient to recapitulate the endogenous spatial expression of hes6 mRNA in the PSM.
Identification of PT enhancer suggests transcriptional regulation of hes6 by T-box and Ets transcription factors
We further showed that the putative binding sites for the T-box and Ets transcription factors within the core regulatory sequence of the PT enhancer were required for the enhancer activity. Although FGF signaling was shown to regulate the expression of hes6 in the posterior PSM (Kawamura et al., 2005; Stulberg et al., 2012) , the precise molecular mechanism of how FGF signaling controls hes6 expression has remained unknown. Here, we showed that Pea3, which is a downstream mediator of the FGF/Ras/MAPK pathway (Raible and Brand, 2001 ), binds to the PT enhancer in a specific manner to regulate the enhancer activity in zebrafish embryos. Zebrafish pea3 is strongly expressed in the PSM and tailbud, where hes6 is also expressed. Furthermore, our data are consistent with the previous quantitative study which showed that the nascent RNA of hes6 is down-regulated by the inhibition of FGF signaling (Stulberg et al., 2012) . Therefore, our results suggest that FGF signaling induces the transcription of hes6 via the induction of Ets transcription factors such as Pea3 in the posterior PSM and tailbud. In addition, we also showed that a T-box transcription factor, Tbx16, can specifically bind to and regulate the PT enhancer. In the PSM of mouse embryos, the expression of the Tbx6 protein, a structural homolog of zebrafish Tbx6 and Tbx16, plays a crucial role in defining the boundaries between future somites (Oginuma et al., 2008) . Also in zebrafish, the gene network that is regulated by several T-box genes has been shown to play an important role in somite patterning. For example, Ntla, Tbx6, and Tbx16, regulate the transcription of her1, deltaC, and deltaD which are involved in somite segmentation (Brend and Holley, 2009a; Garnett et al., 2009; Jahangiri et al., 2012) . Since knockdown of either tbx16 or pea3 did not influence the reporter gene expression, other T-box genes, such as ntla, tbx6, and tbx6l, and Ets genes, such as etv5a and etv5b/erm, which are also expressed in the PSM and tailbud (Chen et al., 2013; Griffin et al., 1998; Hug et al., 1997; Nikaido et al., 2002; Raible and Brand, 2001) , might redundantly regulate the expression of hes6. hes6 expression in the PSM was previously shown to be regulated by FGF signaling (Kawamura et al., 2005) , and this study has revealed that expression of hes6 is also regulated by RA in zebrafish embryos. Cross-regulatory interactions between RA and FGF signaling in the PSM define the future somite boundaries (Hubaud and Pourquié, 2014; Oates et al., 2012) . For example, RA signaling activates the expression of MKP3, an inhibitor of the MAPK/ERK of the FGF signaling pathway in Xenopus (Moreno and Kintner, 2004 500 bp Fig. 6 . PT enhancer with hes6 3′UTR restricted the EGFP mRNA expression to the PSM. (A) EGFP reporter genes were used to generate the transgenic fish lines, Tg(hes6:EGFPhes6 3′UTR). To generate the reporter gene used in Tg(hes6:EGFP-hes6 3′UTR), a DNA fragment corresponding to SV40pA in the reporter (shown in Fig. 2A Fig. 7 . PT enhancer with 3′UTR of hes6 recapitulated a posterior-to-anterior gradient of hes6 expression within the PSM. (A) EGFP reporter genes were used to generate the transgenic fish lines, Tg(hes6:EGFP-hes6 3′UTR-SV40pA). To generate the reporter gene used in Tg(hes6:EGFP-hes6 3′UTR-SV40pA), a DNA fragment corresponding to hes6 3′ UTR was inserted between EGFP and SV40pA in the reporter gene (shown in Fig. 2A ). (B-J) Two-color fluorescent in situ hybridization. Tg(hes6:EGFP-SV40pA), Tg(hes6:EGFPhes6 3′UTR), and Tg(hes6:EGFP-hes6 3′UTR-SV40pA ) embryos were fixed at the 10-12-somite stage. Confocal images were taken of flat-mounted embryos after yolk removal. Endogenous expression of hes6 is shown by magenta, and expression of EGFP mRNA is shown by green. Antisense probe for hes6 is specific to the open reading frames of hes6. Scale bar in J, 50 μm. (K-R) Expression of EGFP-hes6 3′UTR mRNA was observed in transgenic embryos after treatment with SU5402 and DEAB; expression was similar to the endogenous expression of hes6 mRNA. (K-N) Transient treatment of Tg(hes6:EGFP-hes6 3′UTR) embryos at the 1-2-somite stage with SU5402. EGFP expression was analyzed. (O-R) Treatment of Tg(hes6:EGFP-hes6 3′UTR) embryos from the sphere stage with DEAB. Embryos were fixed at the 10-12-somite stage and EGFP expression was examined. Dorsal views (K-R). Probes used for staining are shown at top-right of each panel. All images were taken at the same magnification. Scale bar in R is 200 μm.
